This topic contains a solution. Click here to go to the answer

Author Question: This device is propellant-free and utilizes mechanical energy in the form of a tension spring to ... (Read 99 times)

AEWBW

  • Hero Member
  • *****
  • Posts: 579
This device is propellant-free and utilizes mechanical energy in the form of a tension spring to deliver medication.
 
  a. Breath-enhanced nebulizer
  b. Breath-actuated jet nebulizer
  c. Ultrasonic nebulizer
  d. Soft-mist inhaler

Question 2

This device is electrically powered and operates on the piezoelectric principle and is capable of high output.
 
  a. Breath-enhanced nebulizer
  b. Breath-actuated jet nebulizer
  c. Ultrasonic nebulizer
  d. Soft-mist inhaler



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

vkodali

  • Sr. Member
  • ****
  • Posts: 357
Answer to Question 1

ANS: D

Answer to Question 2

ANS: C




AEWBW

  • Member
  • Posts: 579
Reply 2 on: Jul 16, 2018
Thanks for the timely response, appreciate it


bigsis44

  • Member
  • Posts: 317
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Though Candida and Aspergillus species are the most common fungal pathogens causing invasive fungal disease in the immunocompromised, infections due to previously uncommon hyaline and dematiaceous filamentous fungi are occurring more often today. Rare fungal infections, once accurately diagnosed, may require surgical debridement, immunotherapy, and newer antifungals used singly or in combination with older antifungals, on a case-by-case basis.

Did you know?

People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.

Did you know?

Asthma is the most common chronic childhood disease in the world. Most children who develop asthma have symptoms before they are 5 years old.

Did you know?

This year, an estimated 1.4 million Americans will have a new or recurrent heart attack.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library